AI FOR SCIENCE · ON THE RECORD
Sanofi
Investor page →On the timeline →
Timeline
- 2026-10-29Nomic Bio and Parse Biosciences start building Cascade, 100 million immune cells read for RNA with matching secreted-protein profiles, and GSK, Pfizer and Sanofi signed onPartnerships
- 2026-10-20Sanofi signs ScionxBio to redesign some of its mRNA drug candidates with a deep-learning platform so they keep making protein for longerPartnerships
- 2026-10-15The European Commission asks companies and foundations to pledge models, computing and software licences to Europe's AI-for-science researchers; seven sign up firstPolicy
- 2026-07-17Sanofi nominates a new target in its Aqemia collaboration, triggering a milestone payment of undisclosed sizePartnerships
Rounds it backed
- 2026-03-20Helixon (Earendil Labs) · Round (unnamed) · $787Mparticipant
- 2025-02Enveda · Series C extension · Sanofi investment, amount not stated; brings Series C to $150Mparticipant
- 2021-11-18Owkin · Strategic · $180Mlead
Rounds on the funding record that name it as an investor, in the role each source gives. Its own rounds are not on the funding board, which covers AI4S startups; the timeline records them as events.
This page compiles what AI4S.fyi has recorded and links each item to its source. It is not a grade of the organization and not its complete history: a blank means the record has not caught up as often as it means nothing happened.